Skip to content
PubMed This is a summary of 49 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 49 referenced papers

Top Authors

Keith A. Choate
Yale University
Masashi Akiyama
Nagoya University
Colin Eric Willoughby
University of Ulster
Francisco Cammarata‐Scalisi
Hospital Regional de Antofagasta
Michele Callea
Meyer Children's Hospital

Top Institutions

Ranked by publications Top 8 institutions
03
04

Nagoya University

Nagoya, Japan

3 papers
05

Hospital Regional de Antofagasta

Antofagasta, Chile

2 papers
06

University of Nebraska Medical Center

Omaha, United States

2 papers
07

Meyer Children's Hospital

Florence, Italy

2 papers
Contributors Michele Callea
08

University of Ulster

Coleraine, United Kingdom

2 papers
Contributors Colin Eric Willoughby

References

References (49)
  1. 1

    Phenotypic variability in gap junction syndromic skin disorders: experience from KID and Clouston syndromes' clinical diagnostics.

    Kutkowska-Kaźmierczak A, Niepokój K, Wertheim-Tysarowska K, et al.

    Journal of applied genetics 2015; (56(3)):329-37 doi:10.1007/s13353-014-0266-1.

    PMID: 25575739
  2. 2

    Oral squamous cell carcinoma in a patient with keratitis-ichthyosis-deafness syndrome: a rare case.

    Homeida L, Wiley RT, Fatahzadeh M

    Oral surgery, oral medicine, oral pathology and oral radiology 2015; (119(4)):e226-32.

    PMID: 25758847
  3. 3

    The supportive care needs of parents caring for a child with a rare disease: A scoping review.

    Pelentsov LJ, Laws TA, Esterman AJ

    Disability and health journal 2015; (8(4)):475-91.

    PMID: 25959710
  4. 4

    Phenotype in a patient with p.D50N mutation in GJB2 gene resemble both KID and Clouston syndromes.

    Markova TG, Brazhkina NB, Bliznech EA, et al.

    International journal of pediatric otorhinolaryngology 2016; (81()):10-4.

    PMID: 26810281
  5. 5

    Connexin 26 (GJB2) mutation in an Argentinean patient with keratitis-ichthyosis-deafness (KID) syndrome: a case report.

    Dalamón VK, Buonfiglio P, Larralde M, et al.

    BMC medical genetics 2016; (17(1)):37 doi:10.1186/s12881-016-0298-y.

    PMID: 27141831
  6. 6

    Comparative functional characterization of novel non-syndromic GJB2 gene variant p.Gly45Arg and lethal syndromic variant p.Gly45Glu.

    Rodriguez-Paris J, Waldhaus J, Gordhandas JA, et al.

    PeerJ 2016; (4()):e2494 doi:10.7717/peerj.2494.

    PMID: 27761313
  7. 7

    Experiences of caregivers of children with inherited metabolic diseases: a qualitative study.

    Siddiq S, Wilson BJ, Graham ID, et al.

    Orphanet journal of rare diseases 2016; (11(1)):168 doi:10.1186/s13023-016-0548-2.

    PMID: 27927250
  8. 8

    Vegetating Candidiasis: A Mimicker of Squamous Cell Carcinoma in Keratitis Ichthyosis Deafness Syndrome.

    Calderón-Castrat X, Vega-Zuñiga J, Velásquez F, Ballona R

    Pediatric dermatology 2017; (34(2)):201-203 doi:10.1111/pde.13069.

    PMID: 28111777
  9. 9

    Severe Phenotype of Keratitis-Ichthyosis-Deafness Syndrome With Presumed Ocular Surface Squamous Neoplasia.

    Serrano-Ahumada AS, Cortes-González V, González-Huerta LM, et al.

    Cornea 2018; (37(2)):252-254 doi:10.1097/ICO.0000000000001387.

    PMID: 29023238
  10. 10

    Cochlear Implantation in Patients with Keratitis-Ichthyosis-Deafness Syndrome: A Report of Two Cases.

    Gumus B, Incesulu A, Pinarbasli MO

    Case reports in otolaryngology 2017; (2017()):3913187 doi:10.1155/2017/3913187.

    PMID: 29098103
  11. 11

    Two Cases of Chronic Candidiasis in Keratitis-Ichthyosis-Deafness Syndrome.

    Bartenstein D, Chung HJ, Hussain S

    The American Journal of dermatopathology 2018; (40(10)):e138-e141 doi:10.1097/DAD.0000000000001178.

    PMID: 29742560
  12. 12

    Successfully Improving Visual Acuity in Keratitis-Ichthyosis-Deafness Syndrome Utilizing Gas-Permeable Lenses: A Case Report.

    Strul S, Straughn P

    Eye & contact lens 2018; (44 Suppl 1()):S330-S332 doi:10.1097/ICL.0000000000000328.

    PMID: 30095531
  13. 13

    Roles of aberrant hemichannel activities due to mutant connexin26 in the pathogenesis of KID syndrome.

    Taki T, Takeichi T, Sugiura K, Akiyama M

    Scientific reports 2018; (8(1)):12824 doi:10.1038/s41598-018-30757-3.

    PMID: 30150638
  14. 14

    More than keratitis, ichthyosis, and deafness: Multisystem effects of lethal GJB2 mutations.

    Lilly E, Bunick CG, Maley AM, et al.

    Journal of the American Academy of Dermatology 2019; (80(3)):617-625 doi:10.1016/j.jaad.2018.09.042.

    PMID: 30287322
  15. 15

    "It is like a jungle gym, and everything is under construction": The parent's perspective of caring for a child with a rare disease.

    Currie G, Szabo J

    Child: care, health and development 2019; (45(1)):96-103 doi:10.1111/cch.12628.

    PMID: 30370696
  16. 16

    Emotional experience in parents of children with Zellweger spectrum disorders: A qualitative study.

    Bose M, Mahadevan M, Schules DR, et al.

    Molecular genetics and metabolism reports 2019; (19()):100459 doi:10.1016/j.ymgmr.2019.100459.

    PMID: 30815361
  17. 17

    [Oral manifestations of KID syndrome: rare clinical case].

    Korolenkova MV, Dmitrieva NA, Babichenko II, et al.

    Stomatologiia 2019; (98(4)):93-95 doi:10.17116/stomat20199804193.

    PMID: 31513158
  18. 18

    A Rare Case of KID Syndrome: The Use of Hydrosurgery and Strategies for Antiseptic Wound Care.

    Kapila AK, De Baerdemaeker R, Bakal F, et al.

    Advances in skin & wound care 2019; (32(10)):1-6 doi:10.1097/01.ASW.0000580480.86585.3a.

    PMID: 31567454
  19. 19

    Allele-Specific Small Interfering RNA Corrects Aberrant Cellular Phenotype in Keratitis-Ichthyosis-Deafness Syndrome Keratinocytes.

    Lee MY, Wang HZ, White TW, et al.

    The Journal of investigative dermatology 2020; (140(5)):1035-1044.e7 doi:10.1016/j.jid.2019.09.022.

    PMID: 31705875
  20. 20

    Clinical, etiopathogenic, and therapeutic aspects of KID syndrome.

    Cammarata-Scalisi F, Willoughby CE, Cárdenas Tadich A, et al.

    Dermatologic therapy 2020; (33(4)):e13507 doi:10.1111/dth.13507.

    PMID: 32367610
  21. 21

    Keratitis-ichthyosis-deafness syndrome: Phenotypic heterogeneity and treatment perspective of patients with p.Asp50Asn GJB2 mutation.

    Asgari T, Naji M, Mansouri P, et al.

    Dermatologic therapy 2020; (33(6)):e14493 doi:10.1111/dth.14493.

    PMID: 33136289
  22. 22

    Inherited ichthyosis and fungal infection: an update on pathogenesis and treatment strategies.

    Miao H, Dong R, Zhang S, et al.

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2021; (19(3)):341-350 doi:10.1111/ddg.14389.

    PMID: 33448147
  23. 23

    Parental mosaic cutaneous-gonadal GJB2 mutation: From epidermal nevus to inherited ichthyosis-deafness syndrome.

    Cohen-Barak E, Mwassi B, Zagairy F, et al.

    The Journal of dermatology 2022; (49(3)):379-382 doi:10.1111/1346-8138.16268.

    PMID: 34889473
  24. 24

    The Clinical Manifestation of p.Asp50Asn Heterozygous Mutation of GJB2 Gene in 3 Members of a Family Is Similar to That of Clouston Syndrome.

    Xu Y, Wang M, Huang L, Hu J

    Annals of dermatology 2022; (34(5)):382-386 doi:10.5021/ad.20.278.

    PMID: 36198631
  25. 25

    Keratitis-ichthyosis-deafness syndrome with lethal p.Ala88Val variant and severe hypercalcemia.

    López-Sundh AE, Escribano-Palomino E, Feito-Rodríguez M, et al.

    American journal of medical genetics. Part A 2023; (191(1)):253-258 doi:10.1002/ajmg.a.63005.

    PMID: 36286624
  26. 26

    Keratitis-ichthyosis-deafness Syndrome with Heterozygous p.D50N in the GJB2 Gene in Two Serbian Adult Patients.

    Kalezić T, Vuković I, Stojković M, et al.

    Balkan journal of medical genetics : BJMG 2022; (25(1)):79-84 doi:10.2478/bjmg-2022-0014.

    PMID: 36880041
  27. 27

    Ocular phenotype and therapeutic interventions in keratitis-ichthyosis-deafness (KID) syndrome.

    Mc Lean K, Bignotti S, Callea M, et al.

    Ophthalmic genetics 2024; (45(1)):16-22 doi:10.1080/13816810.2023.2258218.

    PMID: 37755702
  28. 28

    Ultra-rare ultra-care: Assessing the impact of caring for children with ultra rare diseases.

    Domaradzki J, Walkowiak D

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2024; (48()):78-84 doi:10.1016/j.ejpn.2023.12.003.

    PMID: 38071849
  29. 29

    A web-based psychological support program for caregivers of children with rare chronic diseases: a randomized controlled trial.

    Tutus D, Niemitz M, Plener PL, et al.

    Orphanet journal of rare diseases 2024; (19(1)):27 doi:10.1186/s13023-024-03029-9.

    PMID: 38281056
  30. 30

    Calcium Regulation of Connexin Hemichannels.

    Bayraktar E, Lopez-Pigozzi D, Bortolozzi M

    International journal of molecular sciences 2024; (25(12)) doi:10.3390/ijms25126594.

    PMID: 38928300
  31. 31

    Dental Abnormalities in Congenital Ichthyoses: Case Report and Review of the Literature.

    Maarouf S, Clark M, Chen A, Haggstrom A

    Pediatric dermatology 2025; (42(2)):305-310 doi:10.1111/pde.15841.

    PMID: 39659087
  32. 32

    Suspect dyskeratotic neoformations in a 7-year-old child with keratitis-ichthyosis-deafness syndrome: diagnostic, surgical and wound care management.

    Montanari A, Caroppo F, Amabile A, et al.

    Dermatology reports 2024; (16(4)):9953 doi:10.4081/dr.2024.9953.

    PMID: 39749122
  33. 33

    Two cases of therapeutic scleral lenses for KID syndrome.

    Gagliardi M, Asghari B

    American journal of ophthalmology case reports 2025; (37()):102261 doi:10.1016/j.ajoc.2025.102261.

    PMID: 39927073
  34. 34

    Clinical, biochemical and cell biological characterization of KIDAR syndrome associated with a novel AP1B1 variant.

    Kaniganti T, Gean-Akriv G, Keidar T, et al.

    Molecular genetics and metabolism 2025; (144(4)):109056 doi:10.1016/j.ymgme.2025.109056.

    PMID: 40101690
  35. 35

    Assessing Hemichannel and Gap Junctional Channel Activities in HaCaT Keratinocyte Cells.

    Inal E, Yildirim MA, Mese G

    Methods in molecular biology (Clifton, N.J.) 2025; doi:10.1007/7651_2025_650.

    PMID: 40613983
  36. 36

    Keratitis, Ichthyosis, and Deafness Syndrome with Endocarditis and Myelitis: A Rare Case Report.

    Gizzi G, Didona D, Pascolini G, et al.

    Case reports in dermatology 2025; (17(1)):291-298 doi:10.1159/000546019.

    PMID: 40667477
  37. 37

    Ophthalmologic management in KID syndrome: Long-term clinical experience.

    Estévez-Domínguez R, Rocha-de-Lossada C, Rodríguez-Calvo-de-Mora M, et al.

    Archivos de la Sociedad Espanola de Oftalmologia 2025; (100(10)):625-629 doi:10.1016/j.oftale.2025.07.013.

    PMID: 40721026
  38. 38

    Treatment of Epidermal Pathology in a Pediatric Patient With Keratitis-Ichthyosis-Deafness (KID) Syndrome With Topical Mefenamic Acid.

    Gupta R, Ho A, Brichta L, Yan AC

    Pediatric dermatology 2026; (43(1)):145-148 doi:10.1111/pde.70000.

    PMID: 40814260
  39. 39

    Parental Experiences of Receiving a Rare Genetic Disease Diagnosis for Their Child on Diagnosis Day.

    Bullock I, Malone KF, Turnwald A

    American journal of medical genetics. Part A 2026; (200(1)):67-76 doi:10.1002/ajmg.a.64223.

    PMID: 40820471
  40. 40

    Hypodontia in a child with keratitis-ichthyosis-deafness (KID) syndrome: a case report.

    Saleh TS, Poulsen T, Nyman JE

    Journal of medical case reports 2025; (19(1)):431 doi:10.1186/s13256-025-05504-8.

    PMID: 40883811
  41. 41

    Cochlear implantation in patients with keratitis-ichthyosis-deafness syndrome: A systematic review.

    Pearce AN, Farsi S, Saadi CC, et al.

    International journal of pediatric otorhinolaryngology 2025; (197()):112530 doi:10.1016/j.ijporl.2025.112530.

    PMID: 40889428
  42. 42

    Expanding the clinical spectrum: A case report of the first Jordanian presentation of KID syndrome with neurological and skeletal anomalies beyond the classical triad.

    Al-Bustanji R, AlRababah BK, Rumman MSA, et al.

    Medicine 2025; (104(47)):e45577 doi:10.1097/MD.0000000000045577.

    PMID: 41305774
  43. 43

    Novel homozygous pathogenic AP1B1 variant in autosomal recessive keratitis-ichthyosis-deafness syndrome treated with acitretin.

    Caetano DG, Martins F, Soares J, Ramos LC

    BMJ case reports 2025; (18(12)) doi:10.1136/bcr-2025-269396.

    PMID: 41453769
  44. 44

    Case Report of Wound Treatment with Hyiodine Gel in an Occasional KID Syndrome Patient.

    Hajská M, Bittner Fialová S, Dubovský M, Panyko A

    Journal of clinical medicine 2025; (15(1)) doi:10.3390/jcm15010011.

    PMID: 41517259
  45. 45

    Expanding the Clinical Spectrum of KIDAR Syndrome: A Case of Multisystemic Involvement in a Palestinian Child with AP1B1 Deficiency.

    Issa K, Dawoud AMY, Khader ZWR, et al.

    Sage open pediatrics 2026; (13()):30502225261436884 doi:10.1177/30502225261436884.

    PMID: 41948131
  46. 46

    Further delineation of KIDAR syndrome: Two new cases with novel variants, functional analysis of the variants and a comprehensive review.

    Altıner Ş, Gökpınar İli E, Yurtdaş AK, et al.

    Journal of human genetics 2026; (71(8)):513-520 doi:10.1038/s10038-026-01476-9.

    PMID: 42032344
  47. 47

    Prenatal Diagnosis of Keratitis-Ichthyosis-Deafness Syndrome With Dandy Walker Malformation: A Case Report.

    Bourdil L, Georgia Blume C

    Case reports in obstetrics and gynecology 2026; (2026()):5451804 doi:10.1155/crog/5451804.

    PMID: 42433619
  48. 48

    The clinical and genetic landscape of junctional skin disorder in children: A scoping review.

    Del Vecchio C, Nardacchione EM, Zupin L, et al.

    Clinics in dermatology 2026; doi:10.1016/j.clindermatol.2026.09.014.

    PMID: 42759580
  49. 49

    Beyond illness severity: transdiagnostic cognitive vulnerabilities as independent predictors of psychological distress in parents of children with rare genetic disorders.

    Cuturilo G, Vukosavljevic Gvozden T, Gvozden M, et al.

    Frontiers in psychiatry 2026; (17()):1963031 doi:10.3389/fpsyt.2026.1963031.

    PMID: 42871252